April 24, 2018, 1:14 pm
Facebook iconTwitter iconYouTube iconGoogle+ icon
1 Philippine Peso = 0.07044 UAE Dirham
1 Philippine Peso = 2.01285 Albanian Lek
1 Philippine Peso = 0.03414 Neth Antilles Guilder
1 Philippine Peso = 0.3869 Argentine Peso
1 Philippine Peso = 0.02498 Australian Dollar
1 Philippine Peso = 0.03414 Aruba Florin
1 Philippine Peso = 0.03836 Barbados Dollar
1 Philippine Peso = 1.59992 Bangladesh Taka
1 Philippine Peso = 0.03047 Bulgarian Lev
1 Philippine Peso = 0.00723 Bahraini Dinar
1 Philippine Peso = 33.58228 Burundi Franc
1 Philippine Peso = 0.01918 Bermuda Dollar
1 Philippine Peso = 0.025 Brunei Dollar
1 Philippine Peso = 0.13157 Bolivian Boliviano
1 Philippine Peso = 0.06531 Brazilian Real
1 Philippine Peso = 0.01918 Bahamian Dollar
1 Philippine Peso = 1.26103 Bhutan Ngultrum
1 Philippine Peso = 0.18432 Botswana Pula
1 Philippine Peso = 383.96625 Belarus Ruble
1 Philippine Peso = 0.03832 Belize Dollar
1 Philippine Peso = 0.02447 Canadian Dollar
1 Philippine Peso = 0.01871 Swiss Franc
1 Philippine Peso = 11.4346 Chilean Peso
1 Philippine Peso = 0.12071 Chinese Yuan
1 Philippine Peso = 52.91139 Colombian Peso
1 Philippine Peso = 10.76908 Costa Rica Colon
1 Philippine Peso = 0.01918 Cuban Peso
1 Philippine Peso = 1.72344 Cape Verde Escudo
1 Philippine Peso = 0.3961 Czech Koruna
1 Philippine Peso = 3.39145 Djibouti Franc
1 Philippine Peso = 0.1164 Danish Krone
1 Philippine Peso = 0.94764 Dominican Peso
1 Philippine Peso = 2.1869 Algerian Dinar
1 Philippine Peso = 0.24445 Estonian Kroon
1 Philippine Peso = 0.33832 Egyptian Pound
1 Philippine Peso = 0.52167 Ethiopian Birr
1 Philippine Peso = 0.01562 Euro
1 Philippine Peso = 0.03879 Fiji Dollar
1 Philippine Peso = 0.01369 Falkland Islands Pound
1 Philippine Peso = 0.01368 British Pound
1 Philippine Peso = 0.08493 Ghanaian Cedi
1 Philippine Peso = 0.89893 Gambian Dalasi
1 Philippine Peso = 172.6122 Guinea Franc
1 Philippine Peso = 0.1407 Guatemala Quetzal
1 Philippine Peso = 3.94879 Guyana Dollar
1 Philippine Peso = 0.15041 Hong Kong Dollar
1 Philippine Peso = 0.4519 Honduras Lempira
1 Philippine Peso = 0.11558 Croatian Kuna
1 Philippine Peso = 1.23341 Haiti Gourde
1 Philippine Peso = 4.85501 Hungarian Forint
1 Philippine Peso = 266.4557 Indonesian Rupiah
1 Philippine Peso = 0.06754 Israeli Shekel
1 Philippine Peso = 1.26972 Indian Rupee
1 Philippine Peso = 22.70809 Iraqi Dinar
1 Philippine Peso = 805.52361 Iran Rial
1 Philippine Peso = 1.92079 Iceland Krona
1 Philippine Peso = 2.37438 Jamaican Dollar
1 Philippine Peso = 0.01359 Jordanian Dinar
1 Philippine Peso = 2.06782 Japanese Yen
1 Philippine Peso = 1.91408 Kenyan Shilling
1 Philippine Peso = 1.31497 Kyrgyzstan Som
1 Philippine Peso = 76.83161 Cambodia Riel
1 Philippine Peso = 7.65286 Comoros Franc
1 Philippine Peso = 17.26122 North Korean Won
1 Philippine Peso = 20.47315 Korean Won
1 Philippine Peso = 0.00575 Kuwaiti Dinar
1 Philippine Peso = 0.01573 Cayman Islands Dollar
1 Philippine Peso = 6.25738 Kazakhstan Tenge
1 Philippine Peso = 158.78405 Lao Kip
1 Philippine Peso = 28.8646 Lebanese Pound
1 Philippine Peso = 2.99962 Sri Lanka Rupee
1 Philippine Peso = 2.50441 Liberian Dollar
1 Philippine Peso = 0.23188 Lesotho Loti
1 Philippine Peso = 0.05847 Lithuanian Lita
1 Philippine Peso = 0.0119 Latvian Lat
1 Philippine Peso = 0.02539 Libyan Dinar
1 Philippine Peso = 0.17621 Moroccan Dirham
1 Philippine Peso = 0.31433 Moldovan Leu
1 Philippine Peso = 0.95589 Macedonian Denar
1 Philippine Peso = 25.29728 Myanmar Kyat
1 Philippine Peso = 45.79977 Mongolian Tugrik
1 Philippine Peso = 0.15492 Macau Pataca
1 Philippine Peso = 6.75105 Mauritania Ougulya
1 Philippine Peso = 0.64212 Mauritius Rupee
1 Philippine Peso = 0.29862 Maldives Rufiyaa
1 Philippine Peso = 13.71883 Malawi Kwacha
1 Philippine Peso = 0.35542 Mexican Peso
1 Philippine Peso = 0.07476 Malaysian Ringgit
1 Philippine Peso = 0.23032 Namibian Dollar
1 Philippine Peso = 6.88531 Nigerian Naira
1 Philippine Peso = 0.59455 Nicaragua Cordoba
1 Philippine Peso = 0.15025 Norwegian Krone
1 Philippine Peso = 2.02693 Nepalese Rupee
1 Philippine Peso = 0.02661 New Zealand Dollar
1 Philippine Peso = 0.00738 Omani Rial
1 Philippine Peso = 0.01918 Panama Balboa
1 Philippine Peso = 0.06167 Peruvian Nuevo Sol
1 Philippine Peso = 0.06232 Papua New Guinea Kina
1 Philippine Peso = 1 Philippine Peso
1 Philippine Peso = 2.21711 Pakistani Rupee
1 Philippine Peso = 0.06525 Polish Zloty
1 Philippine Peso = 105.81128 Paraguayan Guarani
1 Philippine Peso = 0.06981 Qatar Rial
1 Philippine Peso = 0.07297 Romanian New Leu
1 Philippine Peso = 1.17426 Russian Rouble
1 Philippine Peso = 16.19889 Rwanda Franc
1 Philippine Peso = 0.07192 Saudi Arabian Riyal
1 Philippine Peso = 0.14921 Solomon Islands Dollar
1 Philippine Peso = 0.25758 Seychelles Rupee
1 Philippine Peso = 0.34621 Sudanese Pound
1 Philippine Peso = 0.1621 Swedish Krona
1 Philippine Peso = 0.02526 Singapore Dollar
1 Philippine Peso = 0.01369 St Helena Pound
1 Philippine Peso = 0.42589 Slovak Koruna
1 Philippine Peso = 146.33679 Sierra Leone Leone
1 Philippine Peso = 10.79785 Somali Shilling
1 Philippine Peso = 382.92676 Sao Tome Dobra
1 Philippine Peso = 0.16782 El Salvador Colon
1 Philippine Peso = 9.87687 Syrian Pound
1 Philippine Peso = 0.2317 Swaziland Lilageni
1 Philippine Peso = 0.60153 Thai Baht
1 Philippine Peso = 0.04709 Tunisian Dinar
1 Philippine Peso = 0.04287 Tongan paʻanga
1 Philippine Peso = 0.07793 Turkish Lira
1 Philippine Peso = 0.12937 Trinidad Tobago Dollar
1 Philippine Peso = 0.56552 Taiwan Dollar
1 Philippine Peso = 43.65171 Tanzanian Shilling
1 Philippine Peso = 0.50153 Ukraine Hryvnia
1 Philippine Peso = 70.73264 Ugandan Shilling
1 Philippine Peso = 0.01918 United States Dollar
1 Philippine Peso = 0.54066 Uruguayan New Peso
1 Philippine Peso = 154.48792 Uzbekistan Sum
1 Philippine Peso = 1138.30075 Venezuelan Bolivar
1 Philippine Peso = 436.67051 Vietnam Dong
1 Philippine Peso = 2.02071 Vanuatu Vatu
1 Philippine Peso = 0.04846 Samoa Tala
1 Philippine Peso = 10.24242 CFA Franc (BEAC)
1 Philippine Peso = 0.05178 East Caribbean Dollar
1 Philippine Peso = 10.24242 CFA Franc (BCEAO)
1 Philippine Peso = 1.85386 Pacific Franc
1 Philippine Peso = 4.79287 Yemen Riyal
1 Philippine Peso = 0.23169 South African Rand
1 Philippine Peso = 99.53011 Zambian Kwacha
1 Philippine Peso = 6.94093 Zimbabwe dollar

Aquino: No rush, no protests on Dengvaxia

FORMER President Benigno Simeon Aquino III yesterday said there was no undue haste in the approval of the purchase of P3.5-billion worth of dengue vaccines during his administration. 

Aquino, during the resumption of the Senate blue ribbon committee hearings on the purchase of the Dengvaxia vaccines, also confirmed that he met with officials of Sanofi Pasteur, the vaccine’s manufacturer, twice but no one told him about the firm’s flecked record abroad or the issues against Dengvaxia.

The former president said he met with officials of the French pharmaceutical company on Dec. 1, 2015 while he was in Paris for the UN Conference on Climate Change. At the sidelines of the conference, he met businessmen from Vivapolis, Airbus, Jacobi, CRH, Usine IO and Sanofi.

It was then, he said, that Sanofi officials told him that the vaccines were ready.

On Dec. 10, 2015, then Health Secretary Janette Garin submitted a proposal to the Department of Budget and Management (DBM) for health facilities enhancement program (HFEP) funding and procurement of dengue vaccines.

On Dec. 23, a memorandum was issued by then Budget Secretary Florencio Abad to fund projects from the Miscellaneous Personnel Benefits Fund (MPBF) and Pension Gratuity Fund (PGF) savings. Among the projects identified was the dengue vaccination program.

On Dec. 29, a Special Allotment Release Order (SARO) was issued by the DBM to the DOH, obligating P3.5 billion for the vaccination program.

Aquino explained that savings had to be used to purchase the vaccines, because if not, “you are practically saying that the first implementation of this vaccine will be in 2017 because it will be for the next budget cycle, which will be under the new administration.”

He also said there was no guarantee the vaccines will be administered considering a “learning curve” at the start of every presidency.

“The choice is simple. We can implement it at this point in time for the protection – or wait at least a year as minimum and expose our people to a risk that could have been prevented because of this vaccine,” he added.

Aquino, in his opening statement, said before he approved the purchase of Dengvaxia, while he was still deciding, and even after he decided, no one protested.

He said Dengvaxia was given to 830,000 children in Metro Manila, Calabarzon and Central Luzon because data from the Department of Health showed that they were the regions most affected by dengue in 2015.

He said if he let his “bosses” suffer despite the existence of the vaccines, his critics would then accuse him of negligence.

Aquino said his administration began to focus on dengue after receiving a memorandum from former health secretary Enrique Ona dated Aug. 23, 2010, which highlighted the prevalence of dengue in five regions affecting around 2.8 million people.

He said two of the regions had more than 100 percent increase in dengue cases. Another, he said, had a 1,409.5 percent rise in cases.

Aquino said the vaccine went through “local and international processes.”

He said he was told that the US Food and Drug Administration regulates international clinical trials and that Dengvaxia underwent the process.

Besides, it was not only the Philippines that approved the administration of vaccines.  He said Mexico and Brazil did as well.

The vaccination program began on April 2016, just a month before the May presidential elections.

He said when he approved the purchase of the vaccines, he was not aware of the controversial issues faced by Sanofi Pasteur.

Senate blue ribbon committee chair Richard Gordon, during the hearing, enumerated a list of charges against Sanofi in other parts of the world.

He cited an instance back in 2012 when Sanofi was fined $109 million in the United States for violating the False Claims Act. Sanofi was also accused of bribery in several instances in the past.

Gordon also said there was a rush to buy Dengvaxia and that the vaccines were nearing expiration when they are purchased. He said the earlier expiry date was September 2017.

Sanofi officials said the vaccines had more than 18 months of life, which means they comply with DOH requirements.

Former health secretary Paulyn Ubial told the Senate hearing that she was under a lot of pressure from local officials after she halted dengue vaccination when she become health chief.

Ubial said among those who pressured her into introducing Dengvaxia was Garin’s husband, Iloilo Rep. Oscar Garin Jr. She said Cebu Rep. Gwendolyn Garcia badgered her into including Region VII in the dengue vaccination program. 

She linked her non-confirmation in the Commission on Appointments to the Dengvaxia fiasco.
 
NO PANIC

Thomas Triomphe, the head of Sanofi Pasteur for the Asia-Pacific region, said Dengvaxia continues to be safe and effective in providing persistent protection against the dengue infection.

Triomphe told senators that there is no “world-wide” scare over the Dengvaxia vaccine, which continues to be marketed and used in 10 other countries.

He also said there is no intent to downplay the risks of receiving the dengue vaccine if one had not been infected by the virus.

“There was no intent to downplay, there was an intent to clarify,” Triomphe said. “When we used the word ‘severe dengue,’ it’s not our choice. It’s the wording of severe dengue defined in the protocol of the clinical trial which was started in 2011.”

Triomphe said the word “severe” was too broad and constitutes different grades of classification.

He said Sanofi Pasteur is ready to “collaborate and reengage” with the Department of Health in contributing to the investigations to be done by the task forces on the review of the government’s dengue immunization program.

The World Health Organization yesterday advised member-states to limit the use of Dengvaxia to those previously infected with the dengue virus.

In a statement, the WHO said it is following the position of the Global Advisory Committee on Vaccine Safety based on the new evidence communicated by the vaccine’s manufacturer, Sanofi Pasteur.

“Dengvaxia prevents disease in the majority of vaccine recipients but it should not be administered to people who have not previously been infected with dengue virus,” said the WHO.

It noted how that latest findings of Sanofi Pasteur indicated an increase in incidence of hospitalization and severe illness in vaccinated children never infected with dengue.

Aside from limiting the target market for the dengue vaccine, the WHO said it is imperative for member-states that had approved the use of Dengvaxia to enhance its efforts to combat the disease.

President Duterte, on the eve of the testimony of former president Aquino in the Senate, said he has no plans of filing cases against former presidents.

Duterte said he would rather confront, or even shoot, political rivals for issues and misunderstandings rather than file a law suit.

Prior to his pronouncement, the President said he believed that the former administration undertook the dengue vaccine program in good faith.

Duterte said the program was implemented based on the information that the previous administration had and it was undertaken without knowledge that the latest controversy and questions about the safety of the Dengvaxia vaccine would surface. – With Jocelyn Montemayor and Gerard Naval
Category: 
Rating: 
No votes yet

Column of the Day

New policy on sale of US weapons

By REY O. ARCILLA | April 24,2018
‘We could benefit from the new policy but for the fact that, as an official of the US State Department said, the US Congress will still have the final say in approving any sale.’

Opinion of the Day

Heart, like, sad, angry? Emoticons for issues

By ABIGAIL VALTE | April 24, 2018
‘It is certainly appreciated by those who are sick and utterly tired of all the fake news being peddled by propagandists and paid trolls.’